ID   S19A1_HUMAN             Reviewed;         591 AA.
AC   P41440; B2R7U8; B7Z8C3; E9PFY4; O00553; O60227; Q13026; Q9BTX8;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 3.
DT   28-JUN-2023, entry version 188.
DE   RecName: Full=Reduced folate transporter {ECO:0000305};
DE            Short=FOLT {ECO:0000303|PubMed:7826387};
DE   AltName: Full=Cyclic dinucleotide:anion antiporter SLC19A1 {ECO:0000305|PubMed:31126740, ECO:0000305|PubMed:31511694};
DE   AltName: Full=Folate:anion antiporter SLC19A1 {ECO:0000305|PubMed:10787414, ECO:0000305|PubMed:14609557, ECO:0000305|PubMed:22554803};
DE   AltName: Full=Intestinal folate carrier 1 {ECO:0000303|PubMed:9041240};
DE            Short=IFC-1 {ECO:0000303|PubMed:9041240};
DE   AltName: Full=Placental folate transporter {ECO:0000303|PubMed:7826387};
DE   AltName: Full=Reduced folate carrier protein {ECO:0000303|PubMed:7615551};
DE            Short=RFC {ECO:0000303|PubMed:22554803, ECO:0000303|PubMed:7615551};
DE            Short=hRFC {ECO:0000303|PubMed:16115875};
DE   AltName: Full=Reduced folate transporter 1 {ECO:0000303|PubMed:10787414};
DE            Short=RFT-1 {ECO:0000303|PubMed:10787414};
DE   AltName: Full=Solute carrier family 19 member 1 {ECO:0000305};
DE            Short=hSLC19A1 {ECO:0000303|PubMed:31511694};
GN   Name=SLC19A1 {ECO:0000312|HGNC:HGNC:10937};
GN   Synonyms=FLOT1, RFC1 {ECO:0000303|PubMed:7615551};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   VARIANT ARG-27.
RC   TISSUE=Placenta;
RX   PubMed=7826387; DOI=10.1006/bbrc.1995.1096;
RA   Prasad P.D., Ramamoorthy S., Leibach F.H., Ganapathy V.;
RT   "Molecular cloning of the human placental folate transporter.";
RL   Biochem. Biophys. Res. Commun. 206:681-687(1995).
RN   [2]
RP   SEQUENCE REVISION TO 490-527.
RA   Prasad P.D.;
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANT ARG-27.
RX   PubMed=7615551; DOI=10.1074/jbc.270.29.17468;
RA   Wong S.C., Proefke A., Bhushan A., Matherly L.H.;
RT   "Isolation of human cDNAs that restore methotrexate sensitivity and reduced
RT   folate carrier activity in methotrexate transport-defective Chinese hamster
RT   ovary cells.";
RL   J. Biol. Chem. 270:17468-17475(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANT ARG-27.
RC   TISSUE=Testis;
RX   PubMed=7641195;
RA   Moscow J.A., Gong M., He R., Sgagias M.K., Dixon K.H., Anzick S.L.,
RA   Meltzer P.S., Cowan K.H.;
RT   "Isolation of a gene encoding a human reduced folate carrier (RFC1) and
RT   analysis of its expression in transport-deficient, methotrexate-resistant
RT   human breast cancer cells.";
RL   Cancer Res. 55:3790-3794(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Lymphoma;
RX   PubMed=7852378; DOI=10.1074/jbc.270.7.2987;
RA   Williams F.M., Flintoff W.F.;
RT   "Isolation of a human cDNA that complements a mutant hamster cell defective
RT   in methotrexate uptake.";
RL   J. Biol. Chem. 270:2987-2992(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-27.
RC   TISSUE=Liver;
RX   PubMed=9602167; DOI=10.1016/s0378-1119(98)00123-1;
RA   Tolner B., Roy K., Sirotnak F.M.;
RT   "Structural analysis of the human RFC-1 gene encoding a folate transporter
RT   reveals multiple promoters and alternatively spliced transcripts with 5'
RT   end heterogeneity.";
RL   Gene 211:331-341(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Small intestine;
RX   PubMed=9041240; DOI=10.1053/gast.1997.v112.pm9041240;
RA   Nguyen T.T., Dyer D.L., Dunning D.D., Rubin S.A., Grant K.E., Said H.M.;
RT   "Human intestinal folate transport: cloning, expression, and distribution
RT   of complementary RNA.";
RL   Gastroenterology 112:783-791(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Thymus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT ARG-27.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   FUNCTION, GLYCOSYLATION AT ASN-58, AND MUTAGENESIS OF ASN-58.
RX   PubMed=9767079; DOI=10.1016/s0005-2736(98)00118-7;
RA   Wong S.C., Zhang L., Proefke S.A., Matherly L.H.;
RT   "Effects of the loss of capacity for N-glycosylation on the transport
RT   activity and cellular localization of the human reduced folate carrier.";
RL   Biochim. Biophys. Acta 1375:6-12(1998).
RN   [13]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=10347183; DOI=10.1074/jbc.274.23.16269;
RA   Ferguson P.L., Flintoff W.F.;
RT   "Topological and functional analysis of the human reduced folate carrier by
RT   hemagglutinin epitope insertion.";
RL   J. Biol. Chem. 274:16269-16278(1999).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=10787414; DOI=10.1074/jbc.m002328200;
RA   Chancy C.D., Kekuda R., Huang W., Prasad P.D., Kuhnel J.M., Sirotnak F.M.,
RA   Roon P., Ganapathy V., Smith S.B.;
RT   "Expression and differential polarization of the reduced-folate
RT   transporter-1 and the folate receptor alpha in mammalian retinal pigment
RT   epithelium.";
RL   J. Biol. Chem. 275:20676-20684(2000).
RN   [15]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=14609557; DOI=10.1016/j.exer.2003.08.013;
RA   Naggar H., Fei Y.J., Ganapathy V., Smith S.B.;
RT   "Regulation of reduced-folate transporter-1 (RFT-1) by homocysteine and
RT   identity of transport systems for homocysteine uptake in retinal pigment
RT   epithelial (RPE) cells.";
RL   Exp. Eye Res. 77:687-697(2003).
RN   [16]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15337749; DOI=10.1074/jbc.m408696200;
RA   Witt T.L., Stapels S.E., Matherly L.H.;
RT   "Restoration of transport activity by co-expression of human reduced folate
RT   carrier half-molecules in transport-impaired K562 cells: localization of a
RT   substrate binding domain to transmembrane domains 7-12.";
RL   J. Biol. Chem. 279:46755-46763(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16115875; DOI=10.1074/jbc.m507295200;
RA   Hou Z., Stapels S.E., Haska C.L., Matherly L.H.;
RT   "Localization of a substrate binding domain of the human reduced folate
RT   carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-
RT   substituted accessibility methods.";
RL   J. Biol. Chem. 280:36206-36213(2005).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499 AND SER-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=22554803; DOI=10.1124/mol.112.078642;
RA   Visentin M., Zhao R., Goldman I.D.;
RT   "Augmentation of reduced folate carrier-mediated folate/antifolate
RT   transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide
RT   riboside monophosphate.";
RL   Mol. Pharmacol. 82:209-216(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5 AND SER-225, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=31511694; DOI=10.1038/s41586-019-1553-0;
RA   Luteijn R.D., Zaver S.A., Gowen B.G., Wyman S.K., Garelis N.E., Onia L.,
RA   McWhirter S.M., Katibah G.E., Corn J.E., Woodward J.J., Raulet D.H.;
RT   "SLC19A1 transports immunoreactive cyclic dinucleotides.";
RL   Nature 573:434-438(2019).
RN   [25]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=31126740; DOI=10.1016/j.molcel.2019.05.006;
RA   Ritchie C., Cordova A.F., Hess G.T., Bassik M.C., Li L.;
RT   "SLC19A1 is an importer of the immunotransmitter cGAMP.";
RL   Mol. Cell 0:0-0(2019).
RN   [26]
RP   INVOLVEMENT IN MEGAF, VARIANT MEGAF PHE-212 DEL, CHARACTERIZATION OF
RP   VARIANT MEGAF PHE-212 DEL, AND FUNCTION.
RX   PubMed=32276275; DOI=10.1182/blood.2019003178;
RA   Svaton M., Skvarova Kramarzova K., Kanderova V., Mancikova A., Smisek P.,
RA   Jesina P., Krijt J., Stiburkova B., Dobrovolny R., Sokolova J.,
RA   Bakardjieva-Mihaylova V., Vodickova E., Rackova M., Stuchly J., Kalina T.,
RA   Stary J., Trka J., Fronkova E., Kozich V.;
RT   "A homozygous deletion in the SLC19A1 gene as a cause of folate-dependent
RT   recurrent megaloblastic anemia.";
RL   Blood 135:2427-2431(2020).
CC   -!- FUNCTION: Antiporter that mediates the import of reduced folates or a
CC       subset of cyclic dinucleotides, driven by the export of organic anions
CC       (PubMed:7826387, PubMed:9041240, PubMed:10787414, PubMed:15337749,
CC       PubMed:16115875, PubMed:22554803, PubMed:31511694, PubMed:31126740,
CC       PubMed:32276275). Mechanistically, acts as a secondary active
CC       transporter, which exports intracellular organic anions down their
CC       concentration gradients to facilitate the uptake of its substrates
CC       (PubMed:22554803, PubMed:31511694, PubMed:31126740). Has high affinity
CC       for N5-methyltetrahydrofolate, the predominant circulating form of
CC       folate (PubMed:10787414, PubMed:14609557, PubMed:22554803). Also able
CC       to mediate the import of antifolate drug methotrexate (PubMed:7615551,
CC       PubMed:7641195, PubMed:9767079, PubMed:22554803). Also acts as an
CC       importer of immunoreactive cyclic dinucleotides, such as cyclic GMP-AMP
CC       (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in
CC       the cytosol, and its linkage isomer 3'-3'-cGAMP, thus playing a role in
CC       triggering larger immune responses (PubMed:31511694, PubMed:31126740).
CC       5-amino-4-imidazolecarboxamide riboside (AICAR), when phosphorylated to
CC       AICAR monophosphate, can serve as an organic anion for antiporter
CC       activity (PubMed:22554803). {ECO:0000269|PubMed:10787414,
CC       ECO:0000269|PubMed:14609557, ECO:0000269|PubMed:15337749,
CC       ECO:0000269|PubMed:16115875, ECO:0000269|PubMed:22554803,
CC       ECO:0000269|PubMed:31126740, ECO:0000269|PubMed:31511694,
CC       ECO:0000269|PubMed:32276275, ECO:0000269|PubMed:7615551,
CC       ECO:0000269|PubMed:7641195, ECO:0000269|PubMed:7826387,
CC       ECO:0000269|PubMed:9041240, ECO:0000269|PubMed:9767079}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(6S)-5-methyl-5,6,7,8-tetrahydrofolate(out) + 5-amino-1-(5-
CC         phospho-beta-D-ribosyl)imidazole-4-carboxamide(in) = (6S)-5-
CC         methyl-5,6,7,8-tetrahydrofolate(in) + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide(out); Xref=Rhea:RHEA:60460,
CC         ChEBI:CHEBI:18608, ChEBI:CHEBI:58475;
CC         Evidence={ECO:0000269|PubMed:14609557, ECO:0000269|PubMed:22554803};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60461;
CC         Evidence={ECO:0000269|PubMed:14609557, ECO:0000269|PubMed:22554803};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2',3'-cGAMP(out) + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide(in) = 2',3'-cGAMP(in) + 5-amino-1-(5-
CC         phospho-beta-D-ribosyl)imidazole-4-carboxamide(out);
CC         Xref=Rhea:RHEA:60464, ChEBI:CHEBI:58475, ChEBI:CHEBI:143093;
CC         Evidence={ECO:0000269|PubMed:31126740, ECO:0000305|PubMed:31511694};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60465;
CC         Evidence={ECO:0000269|PubMed:31126740, ECO:0000305|PubMed:31511694};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',3'-cGAMP(out) + 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide(in) = 3',3'-cGAMP(in) + 5-amino-1-(5-
CC         phospho-beta-D-ribosyl)imidazole-4-carboxamide(out);
CC         Xref=Rhea:RHEA:60468, ChEBI:CHEBI:58475, ChEBI:CHEBI:71501;
CC         Evidence={ECO:0000269|PubMed:31126740};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60469;
CC         Evidence={ECO:0000269|PubMed:31126740};
CC   -!- INTERACTION:
CC       P41440-3; Q7Z3Y9: KRT26; NbExp=3; IntAct=EBI-17438674, EBI-12084444;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10347183,
CC       ECO:0000269|PubMed:10787414, ECO:0000269|PubMed:15337749,
CC       ECO:0000269|PubMed:16115875, ECO:0000269|PubMed:9767079}; Multi-pass
CC       membrane protein {ECO:0000255}. Apical cell membrane
CC       {ECO:0000269|PubMed:10787414}; Multi-pass membrane protein
CC       {ECO:0000255}. Basolateral cell membrane {ECO:0000269|PubMed:10787414};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P41440-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P41440-2; Sequence=VSP_042891;
CC       Name=3;
CC         IsoId=P41440-3; Sequence=VSP_044497;
CC   -!- TISSUE SPECIFICITY: Placenta, liver, and to a much smaller extent, in
CC       lung. {ECO:0000269|PubMed:7826387}.
CC   -!- DISEASE: Megaloblastic anemia, folate-responsive (MEGAF) [MIM:601775]:
CC       An autosomal recessive metabolic disorder characterized by
CC       megaloblastic anemia resulting from decreased folate transport into
CC       erythrocytes. Disease manifestations include hemolytic anemia,
CC       hyperhomocysteinemia, and low vitamin B12. Serum folate levels are
CC       normal, but erythrocyte folate levels are decreased. Treatment with
CC       oral folate corrects the anemia and normalizes homocysteine.
CC       {ECO:0000269|PubMed:32276275}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the reduced folate carrier (RFC) transporter
CC       (TC 2.A.48) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB90483.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U15939; AAA98442.1; -; mRNA.
DR   EMBL; U19720; AAC50180.1; -; mRNA.
DR   EMBL; S78996; AAB35058.1; -; mRNA.
DR   EMBL; U17566; AAA74914.1; -; mRNA.
DR   EMBL; U92873; AAC26162.1; -; Genomic_DNA.
DR   EMBL; U92869; AAC26162.1; JOINED; Genomic_DNA.
DR   EMBL; U92870; AAC26162.1; JOINED; Genomic_DNA.
DR   EMBL; U92871; AAC26162.1; JOINED; Genomic_DNA.
DR   EMBL; U92872; AAC26162.1; JOINED; Genomic_DNA.
DR   EMBL; AF004354; AAB61417.1; -; mRNA.
DR   EMBL; AK303168; BAH13909.1; -; mRNA.
DR   EMBL; AK313125; BAG35945.1; -; mRNA.
DR   EMBL; AL163302; CAB90483.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BX322561; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09331.1; -; Genomic_DNA.
DR   EMBL; BC003068; AAH03068.1; -; mRNA.
DR   CCDS; CCDS13725.1; -. [P41440-1]
DR   CCDS; CCDS56217.1; -. [P41440-2]
DR   CCDS; CCDS56218.1; -. [P41440-3]
DR   PIR; I38924; I38924.
DR   PIR; I52728; I52728.
DR   RefSeq; NP_001192135.1; NM_001205206.1. [P41440-3]
DR   RefSeq; NP_001192136.1; NM_001205207.1. [P41440-2]
DR   RefSeq; NP_919231.1; NM_194255.2. [P41440-1]
DR   RefSeq; XP_011528002.1; XM_011529700.2. [P41440-1]
DR   RefSeq; XP_011528003.1; XM_011529701.2.
DR   RefSeq; XP_011528004.1; XM_011529702.2. [P41440-1]
DR   RefSeq; XP_011528005.1; XM_011529703.2. [P41440-1]
DR   RefSeq; XP_011528006.1; XM_011529704.2.
DR   RefSeq; XP_016883932.1; XM_017028443.1. [P41440-1]
DR   RefSeq; XP_016883935.1; XM_017028446.1.
DR   PDB; 7TX6; EM; 3.30 A; A=1-215, A=242-591.
DR   PDB; 7TX7; EM; 3.80 A; A=1-215, A=242-591.
DR   PDB; 7XPZ; EM; 3.40 A; A=1-506.
DR   PDB; 7XQ0; EM; 3.00 A; A=1-506.
DR   PDB; 7XQ1; EM; 3.40 A; A=1-506.
DR   PDB; 7XQ2; EM; 3.30 A; A=1-506.
DR   PDB; 8DEP; EM; 3.60 A; A=1-215, A=242-591.
DR   PDB; 8GOE; EM; 3.00 A; A=1-506.
DR   PDB; 8GOF; EM; 3.00 A; A=1-506.
DR   PDB; 8HII; EM; 3.57 A; A=24-591.
DR   PDB; 8HIJ; EM; 3.54 A; A=24-591.
DR   PDB; 8HIK; EM; 3.72 A; A=24-591.
DR   PDBsum; 7TX6; -.
DR   PDBsum; 7TX7; -.
DR   PDBsum; 7XPZ; -.
DR   PDBsum; 7XQ0; -.
DR   PDBsum; 7XQ1; -.
DR   PDBsum; 7XQ2; -.
DR   PDBsum; 8DEP; -.
DR   PDBsum; 8GOE; -.
DR   PDBsum; 8GOF; -.
DR   PDBsum; 8HII; -.
DR   PDBsum; 8HIJ; -.
DR   PDBsum; 8HIK; -.
DR   AlphaFoldDB; P41440; -.
DR   SMR; P41440; -.
DR   BioGRID; 112461; 78.
DR   IntAct; P41440; 11.
DR   MINT; P41440; -.
DR   STRING; 9606.ENSP00000308895; -.
DR   BindingDB; P41440; -.
DR   ChEMBL; CHEMBL4833; -.
DR   DrugBank; DB11256; Levomefolic acid.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00642; Pemetrexed.
DR   DrugBank; DB06813; Pralatrexate.
DR   DrugBank; DB01157; Trimetrexate.
DR   DrugCentral; P41440; -.
DR   GuidetoPHARMACOLOGY; 1014; -.
DR   TCDB; 2.A.48.1.1; the reduced folate carrier (rfc) family.
DR   GlyCosmos; P41440; 1 site, No reported glycans.
DR   GlyGen; P41440; 1 site.
DR   iPTMnet; P41440; -.
DR   PhosphoSitePlus; P41440; -.
DR   SwissPalm; P41440; -.
DR   BioMuta; SLC19A1; -.
DR   DMDM; 12643280; -.
DR   EPD; P41440; -.
DR   jPOST; P41440; -.
DR   MassIVE; P41440; -.
DR   MaxQB; P41440; -.
DR   PaxDb; P41440; -.
DR   PeptideAtlas; P41440; -.
DR   ProteomicsDB; 20205; -.
DR   ProteomicsDB; 55462; -. [P41440-1]
DR   ProteomicsDB; 55463; -. [P41440-2]
DR   Antibodypedia; 10491; 126 antibodies from 21 providers.
DR   DNASU; 6573; -.
DR   Ensembl; ENST00000311124.9; ENSP00000308895.4; ENSG00000173638.19. [P41440-1]
DR   Ensembl; ENST00000380010.8; ENSP00000369347.4; ENSG00000173638.19. [P41440-3]
DR   Ensembl; ENST00000485649.3; ENSP00000441772.1; ENSG00000173638.19. [P41440-2]
DR   Ensembl; ENST00000650808.1; ENSP00000498221.1; ENSG00000173638.19. [P41440-3]
DR   GeneID; 6573; -.
DR   KEGG; hsa:6573; -.
DR   MANE-Select; ENST00000311124.9; ENSP00000308895.4; NM_194255.4; NP_919231.1.
DR   UCSC; uc002zhl.3; human. [P41440-1]
DR   AGR; HGNC:10937; -.
DR   CTD; 6573; -.
DR   DisGeNET; 6573; -.
DR   GeneCards; SLC19A1; -.
DR   HGNC; HGNC:10937; SLC19A1.
DR   HPA; ENSG00000173638; Tissue enhanced (choroid).
DR   MalaCards; SLC19A1; -.
DR   MIM; 600424; gene.
DR   MIM; 601775; phenotype.
DR   neXtProt; NX_P41440; -.
DR   OpenTargets; ENSG00000173638; -.
DR   Orphanet; 565785; Methotrexate dose selection.
DR   PharmGKB; PA327; -.
DR   VEuPathDB; HostDB:ENSG00000173638; -.
DR   eggNOG; KOG3810; Eukaryota.
DR   GeneTree; ENSGT00950000183022; -.
DR   HOGENOM; CLU_036909_2_0_1; -.
DR   InParanoid; P41440; -.
DR   OMA; TAYVLFR; -.
DR   OrthoDB; 51626at2759; -.
DR   PhylomeDB; P41440; -.
DR   TreeFam; TF313684; -.
DR   PathwayCommons; P41440; -.
DR   Reactome; R-HSA-196757; Metabolism of folate and pterines.
DR   SignaLink; P41440; -.
DR   SIGNOR; P41440; -.
DR   BioGRID-ORCS; 6573; 24 hits in 1172 CRISPR screens.
DR   ChiTaRS; SLC19A1; human.
DR   GeneWiki; SLC19A1; -.
DR   GenomeRNAi; 6573; -.
DR   Pharos; P41440; Tchem.
DR   PRO; PR:P41440; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; P41440; protein.
DR   Bgee; ENSG00000173638; Expressed in jejunal mucosa and 151 other tissues.
DR   ExpressionAtlas; P41440; baseline and differential.
DR   Genevisible; P41440; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0031526; C:brush border membrane; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0061507; F:2',3'-cyclic GMP-AMP binding; IDA:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; IDA:UniProtKB.
DR   GO; GO:0140360; F:cyclic-GMP-AMP transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0008518; F:folate:monoatomic anion antiporter activity; IDA:UniProtKB.
DR   GO; GO:0005542; F:folic acid binding; IBA:GO_Central.
DR   GO; GO:0008517; F:folic acid transmembrane transporter activity; ISS:BHF-UCL.
DR   GO; GO:0015350; F:methotrexate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; ISS:ARUK-UCL.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISS:ARUK-UCL.
DR   GO; GO:0140361; P:cyclic-GMP-AMP transmembrane import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:1904447; P:folate import across plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098838; P:folate transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0046655; P:folic acid metabolic process; TAS:Reactome.
DR   GO; GO:0015884; P:folic acid transport; IMP:ARUK-UCL.
DR   GO; GO:0051958; P:methotrexate transport; IDA:UniProtKB.
DR   GO; GO:0015711; P:organic anion transport; ISS:ARUK-UCL.
DR   GO; GO:0150104; P:transport across blood-brain barrier; TAS:ARUK-UCL.
DR   GO; GO:0006855; P:xenobiotic transmembrane transport; ISS:ARUK-UCL.
DR   CDD; cd06174; MFS; 1.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR002666; Folate_carrier.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR028339; SLC19A1.
DR   PANTHER; PTHR10686; FOLATE TRANSPORTER; 1.
DR   PANTHER; PTHR10686:SF12; REDUCED FOLATE TRANSPORTER; 1.
DR   Pfam; PF01770; Folate_carrier; 1.
DR   PIRSF; PIRSF028739; Folate_carrier; 1.
DR   PIRSF; PIRSF500793; Folate_transporter_1; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   TIGRFAMs; TIGR00806; rfc; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Antiport; Cell membrane;
KW   Disease variant; Folate-binding; Glycoprotein; Hereditary hemolytic anemia;
KW   Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..591
FT                   /note="Reduced folate transporter"
FT                   /id="PRO_0000178660"
FT   TOPO_DOM        1..23
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        24..44
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        45..70
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        71..89
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        90..95
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        96..116
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        117..123
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        124..144
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        145..159
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        160..177
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        178..186
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        187..203
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        204..259
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        260..287
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        288..309
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        310..327
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        328..333
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        334..354
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        355..360
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        361..378
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        379..394
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        395..419
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        420..433
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   TRANSMEM        434..454
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000305"
FT   TOPO_DOM        455..591
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:10347183"
FT   REGION          407..419
FT                   /note="Required for substrate-binding"
FT                   /evidence="ECO:0000269|PubMed:16115875"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         474
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41438"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P41438"
FT   MOD_RES         499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         503
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   CARBOHYD        58
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:9767079"
FT   VAR_SEQ         1..63
FT                   /note="MVPSSPAVEKQVPVEPGPDPELRSWRHLVCYLCFYGFMAQIRPGESFITPYL
FT                   LGPDKNFTREQ -> MRPQPAEPAPGGRGNEACSIHSE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042891"
FT   VAR_SEQ         432..591
FT                   /note="FQLYSVYFLILSIIYFLGAMLDGLRHCQRGHHPRQPPAQGLRSAAEEKAAQA
FT                   LSVQDKGLGGLQPAQSPPLSPEDSLGAVGPASLEQRQSDPYLAQAPAPQAAEFLSPVTT
FT                   PSPCTLCSAQASGPEAADETCPQLAVHPPGVSKLGLQCLPSDGVQNVNQ -> NEELHV
FT                   ASLSLWKSHLRLAADTLSSEGSSGSGPRSWFLSPTLRAALHGPVCPSEVCPS (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_044497"
FT   VARIANT         27
FT                   /note="H -> R (in dbSNP:rs1051266)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:7615551, ECO:0000269|PubMed:7641195,
FT                   ECO:0000269|PubMed:7826387, ECO:0000269|PubMed:9602167"
FT                   /id="VAR_020210"
FT   VARIANT         212
FT                   /note="Missing (in MEGAF; loss of cellular uptake of
FT                   folates, including methotrexate; dbSNP:rs757838708)"
FT                   /evidence="ECO:0000269|PubMed:32276275"
FT                   /id="VAR_085516"
FT   VARIANT         558
FT                   /note="A -> V (in dbSNP:rs35786590)"
FT                   /id="VAR_052404"
FT   MUTAGEN         58
FT                   /note="N->Q: Completely abolishes N-glycosylation without
FT                   affecting subcellular location or folate:anion antiporter
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:9767079"
FT   CONFLICT        268
FT                   /note="R -> P (in Ref. 1; AAA98442)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        457
FT                   /note="H -> D (in Ref. 4; AAB35058)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        483
FT                   /note="A -> R (in Ref. 4; AAB35058)"
FT                   /evidence="ECO:0000305"
FT   HELIX           20..26
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           29..38
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           48..52
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            55..57
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           61..64
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            65..69
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           70..89
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            90..92
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           93..112
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           116..131
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           133..143
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           146..148
FT                   /evidence="ECO:0007829|PDB:7TX6"
FT   HELIX           149..175
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           182..201
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   STRAND          210..213
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            250..253
FT                   /evidence="ECO:0007829|PDB:7XQ2"
FT   HELIX           254..261
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           265..274
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            275..277
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           278..295
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   STRAND          301..303
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           306..323
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            324..329
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           330..332
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           336..355
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           359..361
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           362..376
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            377..379
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           380..387
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   STRAND          388..390
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           393..417
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   TURN            421..424
FT                   /evidence="ECO:0007829|PDB:7XQ0"
FT   HELIX           428..455
FT                   /evidence="ECO:0007829|PDB:7XQ0"
SQ   SEQUENCE   591 AA;  64868 MW;  0437B1615F5517EB CRC64;
     MVPSSPAVEK QVPVEPGPDP ELRSWRHLVC YLCFYGFMAQ IRPGESFITP YLLGPDKNFT
     REQVTNEITP VLSYSYLAVL VPVFLLTDYL RYTPVLLLQG LSFVSVWLLL LLGHSVAHMQ
     LMELFYSVTM AARIAYSSYI FSLVRPARYQ RVAGYSRAAV LLGVFTSSVL GQLLVTVGRV
     SFSTLNYISL AFLTFSVVLA LFLKRPKRSL FFNRDDRGRC ETSASELERM NPGPGGKLGH
     ALRVACGDSV LARMLRELGD SLRRPQLRLW SLWWVFNSAG YYLVVYYVHI LWNEVDPTTN
     SARVYNGAAD AASTLLGAIT SFAAGFVKIR WARWSKLLIA GVTATQAGLV FLLAHTRHPS
     SIWLCYAAFV LFRGSYQFLV PIATFQIASS LSKELCALVF GVNTFFATIV KTIITFIVSD
     VRGLGLPVRK QFQLYSVYFL ILSIIYFLGA MLDGLRHCQR GHHPRQPPAQ GLRSAAEEKA
     AQALSVQDKG LGGLQPAQSP PLSPEDSLGA VGPASLEQRQ SDPYLAQAPA PQAAEFLSPV
     TTPSPCTLCS AQASGPEAAD ETCPQLAVHP PGVSKLGLQC LPSDGVQNVN Q
//
